Latest

MS

·June 16, 2025·5 min read

Mitochondrial Link to Cerebellar Decline in MS

A new study reveals that mitochondrial dysfunction plays a central role in the loss of Purkinje neurons in the cerebellum, contributing to motor impairments in people with multiple sclerosis (MS). Researchers found that inflammation and demyelination in the cerebellum disrupt the mitochondria—key cellular power sources—leading to energy loss, neuron damage, and ataxia.

Featured Neurology Neuroscience

·May 21, 2025·6 min read

8-Minute MRI Scan Can Diagnose MS Without Lumbar Puncture

A groundbreaking study has shown that multiple sclerosis (MS) can now be accurately diagnosed with a specialized MRI scan, eliminating the need for invasive and often painful lumbar punctures. The scan, which takes just 8 minutes, detects brain lesions centered on veins—a hallmark of MS—using a technique called T2*-weighted MRI.

Featured Neurology Neuroscience

·April 29, 2025·4 min read

AI Model Detects MS Progression Earlier

A new AI model can detect the transition from relapsing-remitting MS to secondary progressive MS much earlier than traditional clinical diagnosis. Using data from over 22,000 patients, the model analyzes routine healthcare information and even indicates its confidence level for each assessment.

Featured Neurology Neuroscience Psychology

·April 18, 2025·5 min read

Disrupted Myelin Protein Implicated in Schizophrenia

A new study has identified the protein hnRNP A1 as a key player in the production and maintenance of myelin, the fatty sheath that insulates nerve fibers in the brain. Myelin loss is common in disorders like multiple sclerosis and schizophrenia, and this research shows that hnRNP A1 disruptions can impair myelination at the molecular level, even before behavioral symptoms appear.

Featured Neurology Neuroscience

·April 8, 2025·6 min read

AI Tool Tracks MS Brain Changes in Seconds

A new AI tool, MindGlide, can rapidly analyze routine brain MRI scans to detect subtle changes caused by multiple sclerosis (MS), such as brain shrinkage and lesions. Traditionally requiring expert interpretation, this process now takes just seconds, allowing more efficient monitoring of disease progression and treatment effects.

Featured Neurology Neuroscience

·March 11, 2025·5 min read

How a Common Virus Triggers Brain Attacks in Multiple Sclerosis

New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of multiple sclerosis (MS). Scientists discovered that these viral antibodies mistakenly target a protein called GlialCAM in the brain, triggering autoimmune responses associated with MS.

Featured Neurology Neuroscience

·February 9, 2023·5 min read

New Biomarker for Disease Progression in Multiple Sclerosis

The blood level of the glial fibrillary acidic protein (GFAP) cellular component increases when astrocytes are damaged or activated. Elevated levels of GFAP in the blood can indicate both the current and future progression of multiple sclerosis.

This shows a man doing a paper maze puzzle

Featured Neurology Neuroscience

·October 30, 2021·3 min read

Vibration Training for Multiple Sclerosis

Vibration training not only improved physical symptoms associated with multiple sclerosis, but it also improved cognitive functions including memory capacity and executive function.

Featured Genetics Neurology Neuroscience

·May 3, 2021·4 min read

Mini 3D Brain Models Could Speed Up Search for MS Treatments

A 3D mini brain, created from human skin cells, will be used to study myelin.

Featured Neurology

·July 28, 2020·3 min read

Mental Fatigue of Multiple Sclerosis Linked to Inefficient Recruitment of Neural Resources

Those with MS allocate neural resources less effectively when faced with increased cognitive task demands, and this likely results in the increased mental fatigue those with the neurodegenerative disorder experience.

Featured Neurology Neuroscience

·March 28, 2020·3 min read

FDA approves ozanimod for treatment of multiple sclerosis

The FDA has approved a new drug named Ozanimod for the treatment of multiple sclerosis. Ozanimod binds to receptors in lymphocytes' surfaces, preventing them from reaching the brain. As the number of active lymphocytes decreases, the attack on the immune system diminishes.

Featured Neurology Neuroscience Open Neuroscience Articles

·February 26, 2020·4 min read

Antioxidant precursor molecule could improve brain function in patients with MS

Multiple sclerosis patients who received N-acetylcysteine treatments had improvements in metabolism in brain areas associated with cognition and attention.

1 2 3 … 10

MS

Mitochondrial Link to Cerebellar Decline in MS

8-Minute MRI Scan Can Diagnose MS Without Lumbar Puncture

AI Model Detects MS Progression Earlier

Disrupted Myelin Protein Implicated in Schizophrenia

AI Tool Tracks MS Brain Changes in Seconds

How a Common Virus Triggers Brain Attacks in Multiple Sclerosis

New Biomarker for Disease Progression in Multiple Sclerosis

Vibration Training for Multiple Sclerosis

Mini 3D Brain Models Could Speed Up Search for MS Treatments

Mental Fatigue of Multiple Sclerosis Linked to Inefficient Recruitment of Neural Resources

FDA approves ozanimod for treatment of multiple sclerosis

Antioxidant precursor molecule could improve brain function in patients with MS

Blurry Beginnings Shape Brain’s Visual Pathways

Human Brains Keep Making Memory Neurons in Adulthood

Gene Therapy Restores Hearing in Those with Deafness

Forever Chemicals May Disrupt Brain Development

Subscribe